Dalvey David 4
4 · Celcuity Inc. · Filed Dec 14, 2023
Insider Transaction Report
Form 4
Celcuity Inc.CELC
Dalvey David
Director
Transactions
- Sale
Common Stock
2023-12-13$14.50/sh−5,000$72,500→ 232,940 total(indirect: By Brightstone Venture Capital Fund, LP) - Sale
Common Stock
2023-12-12$14.61/sh−2,060$30,089→ 237,940 total(indirect: By Brightstone Venture Capital Fund, LP)
Holdings
- 9,325
Common Stock
- 3,201
Stock Option (right to buy)
Exercise: $5.50Exp: 2028-05-14→ Common Stock (3,201 underlying) - 12,654
Stock Option (right to buy)
Exercise: $5.10Exp: 2030-05-14→ Common Stock (12,654 underlying) - 2,310
Stock Option (right to buy)
Exercise: $5.50Exp: 2031-05-12→ Common Stock (2,310 underlying) - 11,645
Stock Option (right to buy)
Exercise: $9.58Exp: 2033-05-15→ Common Stock (11,645 underlying) - 8,200
Stock Option (right to buy)
Exercise: $5.50Exp: 2027-10-19→ Common Stock (8,200 underlying) - 5,054
Stock Option (right to buy)
Exercise: $5.50Exp: 2029-05-16→ Common Stock (5,054 underlying) - 24,449
Stock Option (right to buy)
Exercise: $5.50Exp: 2032-05-17→ Common Stock (24,449 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.60 to $14.66, inclusive. The reporting person undertakes to provide Celcuity Inc., any security holder of Celcuity Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP.
- [F3]100% vested.
- [F4]This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.